The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Lim Jonathan E since year 2005.
The trader's CIK number is 1283290.
At the time of this reporting, Lim Jonathan E is the President, CEO of Halozyme Therapeutics Inc .
(stock ticker symbol HTI).
See this page for all insider trading activities at Halozyme Therapeutics Inc .
Stock purchases, sales, and option exercises reported by insider Lim Jonathan E since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2008-03-20
HALO
Halozyme Therapeutics Inc
Sale
250,000
6.06
1,515,000
2008-03-19
HALO
Halozyme Therapeutics Inc
Option Exercise
230,000
.39
89,700
2007-11-30
HALO
Halozyme Therapeutics Inc
Option Exercise
20,000
.39
7,800
2007-11-30
HALO
Halozyme Therapeutics Inc
Sale
20,000
8.22
164,400
2007-10-31
HALO
Halozyme Therapeutics Inc
Sale
25,000
9.07
226,638
2007-10-31
HALO
Halozyme Therapeutics Inc
Option Exercise
25,000
.39
9,750
2007-10-16
HALO
Halozyme Therapeutics Inc
Option Exercise
26,690
.45
11,999
2007-09-28
HALO
Halozyme Therapeutics Inc
Option Exercise
25,000
.39
9,750
2007-09-28
HALO
Halozyme Therapeutics Inc
Sale
25,000
8.77
219,310
2007-08-31
HALO
Halozyme Therapeutics Inc
Option Exercise
25,000
.39
9,750
2007-08-31
HALO
Halozyme Therapeutics Inc
Sale
12,200
8.53
104,023
2007-08-31
HALO
Halozyme Therapeutics Inc
Sale
12,800
8.83
113,048
2007-07-31
HALO
Halozyme Therapeutics Inc
Option Exercise
20,000
.39
7,800
2007-07-31
HALO
Halozyme Therapeutics Inc
Sale
20,000
8.24
164,706
2007-06-29
HALO
Halozyme Therapeutics Inc
Sale
8,199
9.58
78,566
2007-06-29
HALO
Halozyme Therapeutics Inc
Sale
16,801
9.38
157,645
2007-06-29
HALO
Halozyme Therapeutics Inc
Option Exercise
25,000
.39
9,750
2007-06-25
HALO
Halozyme Therapeutics Inc
Option Exercise
96,313
.39
37,562
2007-05-31
HALO
Halozyme Therapeutics Inc
Option Exercise
12,500
.39
4,875
2007-05-31
HALO
Halozyme Therapeutics Inc
Sale
19,100
10.35
197,737
2007-05-31
HALO
Halozyme Therapeutics Inc
Sale
5,900
10.61
62,599
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Lim Jonathan E
(President, CEO of Halozyme Therapeutics Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
